Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MED IN AS
AS
Active
Org 947788612
Lønnåskollen 42A, 1362 Hosle
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 1988
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 2,3M
-5% vs 2023
EBITDA margin
24.6%
-29% vs 2023
Equity ratio
85.1%
Financial strength
Net profit 2024
NOK 1,3M
+33% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2020
1M
0%
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 2,3M
-5%
EBITDA
NOK 569K
-29%
Net profit
NOK 1,3M
+33%
Total assets
NOK 4,6M
+25%
Equity
NOK 3,9M
+41%
Employees
2
—
Company information
Legal name
MED IN AS
Org number
947788612
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17. mai 1988
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Contact
Address
Lønnåskollen 42A, 1362 Hosle
Phone
+4767147526
Email
post@medin.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Bærum
All Norway companies
Revenue
NOK millions
0M
1M
1M
2M
2M
2M
2020
2M
2021
2M
2022
2M
2023
2M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
1M
2023
1M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 932
2 418
2 446
2 449
2 319
Staff expenses
−561
−565
−567
−676
−832
EBITDA
578
937
938
806
569
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
578
937
938
806
569
Net financials
0
533
−1 714
497
1 019
Profit before tax
578
1 470
−776
1 303
1 588
Tax
128
346
181
296
246
Net profit
450
1 124
−957
1 007
1 342
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
3 452
4 437
2 940
3 674
4 581
Equity
2 783
3 507
2 150
2 757
3 899
Long-term debt
0
0
0
0
0
Short-term debt
669
930
790
916
682
Total debt
669
930
790
916
682
Financial ratios
5-year trend
EBITDA margin
24.6%
This company
15.8%
Market median
+56% vs market
2020
2024
Equity ratio
85.1%
This company
38.2%
Market median
+123% vs market
2020
2024
Return on equity
34.4%
This company
18.4%
Market median
+87% vs market
2020
2024
Net profit margin
57.9%
This company
8.1%
Market median
+615% vs market
2020
2024
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
2020
2024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
EB
Elisabeth Baråt Fjeldheim
Deputy Chairman
2010
JE
Jan Erik Fjeldheim
Chairman
2010
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Camilla Fjeldheim
Individual
6%
6%
2024
Christine Baråt Fjeldheim
Individual
6%
6%
2024
Celine Elton
Individual
6%
6%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of MED IN AS also hold positions in
0
other companies.
Person
Role here
Other companies
Elisabeth Baråt Fjeldheim
Deputy Chairman
0 companies
Jan Erik Fjeldheim
Chairman
0 companies